AP
Antipodes Partners Portfolio holdings
AUM
$3.22B
This Quarter Return
+3.7%
1 Year Return
+24%
3 Year Return
+103.24%
5 Year Return
+233.05%
10 Year Return
–
AUM
$3.19B
AUM Growth
+$3.19B
(+11%)
Cap. Flow
+$270M
Cap. Flow
% of AUM
8.46%
Top 10 Holdings %
Top 10 Hldgs %
51.51%
Holding
116
New
37
Increased
39
Reduced
22
Closed
13
Top Buys
| 1 |
HCA Healthcare
HCA
|
$141M |
| 2 |
JD.com
JD
|
$64.1M |
| 3 |
Keysight
KEYS
|
$46.3M |
| 4 |
Lennar Class A
LEN
|
$41.8M |
| 5 |
Brookdale Senior Living
BKD
|
$38.3M |
Top Sells
| 1 |
AT&T
T
|
$71.9M |
| 2 |
Occidental Petroleum
OXY
|
$36.2M |
| 3 |
Oracle
ORCL
|
$33M |
| 4 |
Qualcomm
QCOM
|
$27.2M |
| 5 |
Alibaba
BABA
|
$24.6M |
Sector Composition
| 1 | Healthcare | 17.87% |
| 2 | Technology | 15.34% |
| 3 | Materials | 14.43% |
| 4 | Financials | 12.5% |
| 5 | Consumer Discretionary | 11.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
MYR Group
MYRG
$2.84B
| $81.3K | ﹤0.01% |
719
+101
| +16% | +$11.4K |
|
77
Establishment Labs
ESTA
$1.11B
| $80.6K | ﹤0.01% |
+1,975
| New | +$80.6K |
|
78
Structure Therapeutics
GPCR
$1.14B
| $73.5K | ﹤0.01% |
4,247
+3,213
| +311% | +$55.6K |
|
79
Ultragenyx Pharmaceutical
RARE
$3.04B
| $56.8K | ﹤0.01% |
+1,568
| New | +$56.8K |
|
80
Certara
CERT
$1.69B
| $53.9K | ﹤0.01% |
5,442
| – | – |
|
81
Lumen
LUMN
$4.84B
| $44.6K | ﹤0.01% |
11,386
| – | – |
|
82
GE Aerospace
GE
$293B
| $40.6K | ﹤0.01% |
203
+34
| +20% | +$6.81K |
|
83
Natera
NTRA
$23B
| $40K | ﹤0.01% |
+283
| New | +$40K |
|
84
Autodesk
ADSK
$67.6B
| $39.5K | ﹤0.01% |
151
+13
| +9% | +$3.4K |
|
85
Nuvalent
NUVL
$5.74B
| $38.3K | ﹤0.01% |
+540
| New | +$38.3K |
|
86
Schrodinger
SDGR
$1.42B
| $37.1K | ﹤0.01% |
+1,878
| New | +$37.1K |
|
87
ARS Pharmaceuticals
SPRY
$1.08B
| $37K | ﹤0.01% |
+2,943
| New | +$37K |
|
88
Exelon
EXC
$43.8B
| $34.2K | ﹤0.01% |
+743
| New | +$34.2K |
|
89
Dominion Energy
D
$50.3B
| $33.9K | ﹤0.01% |
+604
| New | +$33.9K |
|
90
SI-BONE Inc
SIBN
$700M
| $33.6K | ﹤0.01% |
+2,394
| New | +$33.6K |
|
91
Procept Biorobotics
PRCT
$2.11B
| $29.5K | ﹤0.01% |
+507
| New | +$29.5K |
|
92
GE Vernova
GEV
$157B
| $24.1K | ﹤0.01% |
+79
| New | +$24.1K |
|
93
Ingersoll Rand
IR
$30.8B
| $22K | ﹤0.01% |
275
-38
| -12% | -$3.04K |
|
94
Oric Pharmaceuticals
ORIC
$1.03B
| $21.3K | ﹤0.01% |
+3,822
| New | +$21.3K |
|
95
Apogee Therapeutics
APGE
$2.27B
| $20.3K | ﹤0.01% |
+542
| New | +$20.3K |
|
96
908 Devices
MASS
$214M
| $19.6K | ﹤0.01% |
+4,382
| New | +$19.6K |
|
97
Janux Therapeutics
JANX
$1.38B
| $17.1K | ﹤0.01% |
+632
| New | +$17.1K |
|
98
Day One Biopharmaceuticals
DAWN
$766M
| $16.2K | ﹤0.01% |
+2,043
| New | +$16.2K |
|
99
Fluence Energy
FLNC
$884M
| $10K | ﹤0.01% |
2,062
+1,403
| +213% | +$6.81K |
|
100
Array Technologies
ARRY
$1.32B
| $8.97K | ﹤0.01% |
1,841
+98
| +6% | +$477 |
|